• Berberine, RXRα/PPARγ, and SASP in Atherosclerosis

  2026-09-30

  A 2025 study links berberine to suppression of senescence-associated secretory phenotype inflammation through an RXRα/PPARγ/NEDD4 axis in macrophage-derived foam cells and atherosclerotic plaques. Its combination of mouse pathology, foam-cell experiments, Smart-seq analysis, and macrophage-targeted RXRα knockdown provides a mechanistic framework connecting nuclear-receptor signaling with ubiquitin-dependent regulation of the GATA4/p62 complex.

• Reversible Epiblast Regionalization in hPSCs

  2026-09-29

  This study shows that human pluripotent stem cell differentiation bias can arise from reversible anterior–posterior epiblast-like regionalization and locus-specific erosion of bivalent chromatin, rather than DNA methylation changes alone. Its chemical chromatin restoration strategy recovered anterior-like molecular features, neural organoid competence, and broader germ-layer differentiation, offering a framework for evaluating and rescuing compromised hPSC lines.

• Mechanical Stress, Autophagy, and Cytoskeletal Control

  2026-09-29

  The reference study shows that compression-induced autophagy depends primarily on actin-containing microfilaments, while microtubules provide an auxiliary contribution. Its combination of cytoskeletal perturbation, fluorescence-based analysis, and western blotting offers a useful framework for studying how mechanical inputs are converted into autophagic responses.

• RNase Alert-Plus: RNA Integrity Control

  2026-09-28

  RNase Alert-Plus is an RNA workflow control associated with SKU K1903. It can help frame RNase-related testing, but the supplied product dossier does not specify its reporter chemistry, operating conditions, or acceptance limits; those parameters should come from the current product instructions.

• Sulfo-NHS-Biotin for Host–Pathogen Assay Design

  2026-09-28

  Sulfo-NHS-Biotin can add a surface-accessibility layer to host–pathogen experiments without being confused with a functional perturbation. This article connects its chemistry to the findings on GSK3 inhibition in tuberculosis and clarifies what biotinylation can—and cannot—show.

• AG-126: ERK Assays and Circuit-Level Limits

  2026-09-27

  AG-126 (Tyrphostin AG-126) offers a way to interrogate ERK1/2 phosphorylation, but its inflammatory-model evidence should not be mistaken for proof of a mechanism in autism-related striatal circuits. This article maps the evidence boundary and explains how to design experiments that distinguish pathway engagement from behavioral causation.

• Imatinib Hydrochloride: Beyond Target Occupancy

  2026-09-26

  Imatinib hydrochloride is a useful probe of v-Abl, c-Kit, and PDGFR signaling, but interpreting its effects requires more than measuring cell growth. This article connects target engagement to phosphatase-aware assay design while carefully separating a p38α research finding from evidence about imatinib itself.

• EdU Imaging Kits (Cy5) for S-Phase Analysis

  2026-09-25

  Measure DNA synthesis in hypoxia-responsive endothelial cells with a click-chemistry assay designed for fluorescence microscopy and flow cytometry. This practical guide connects EdU pulse-labeling to pulmonary vascular remodeling research, with pilot workflow conditions, interpretation limits, and troubleshooting advice.

• EdU Imaging Kits (Cy5) for HCC Cell-Cycle Studies

  2026-09-25

  EdU Imaging Kits (Cy5) can help distinguish reduced DNA synthesis from broader changes in hepatocellular carcinoma cell populations. This article connects the MEX3A–DHRS3 findings to practical S-phase assay design and interpretation.

• C34 TLR4 Inhibitor: Workflows for Inflammation Research

  2026-09-24

  Use C34 as a pathway-focused perturbation to test whether TLR4 contributes to inflammatory readouts—not as a substitute for cell-specific controls or target validation. This workflow connects macrophage and enterocyte experiments with emerging microglial evidence while distinguishing published findings from practical starting conditions.

• Resiniferatoxin (RTX): TRPV1 Mechanism & Research Use

  2026-09-24

  Resiniferatoxin (RTX) is an ultra-potent TRPV1 agonist used to investigate sensory-neuron desensitization, pain, and neurogenic inflammation. A 2025 mouse study also used RTX to trigger TRPV1 activation and found that topical cyclodextrin pretreatment reduced selected pain and inflammatory responses through cholesterol depletion.

• PX-478 2HCl: Testing HIF-1α Causality

  2026-09-23

  Learn how PX-478 2HCl can help test HIF-1α dependence in hypoxic cancer models—and how findings from cichoric acid research sharpen experimental design without implying the same treatment effect. This guide connects mechanism, controls, and practical study parameters.

• From PLAC1 Biology to Smarter Cancer Screening

  2026-09-23

  PLAC1 is emerging as a biomarker and molecular target in clear cell renal cell carcinoma. This thought-leadership article explains how the L1023 Anti-Cancer Compound Library can help translational researchers connect biomarker biology, phenotypic screening, pathway analysis, and mechanistic validation without overstating early-stage evidence.

• HRP Rabbit Anti-Goat IgG (H+L) Antibody Guide

  2026-09-22

  The HRP Rabbit Anti-Goat IgG (H+L) Antibody is a horseradish peroxidase conjugated secondary antibody for immunodetection of goat primary antibodies. Its affinity purification, HRP signal generation, application-specific starting dilutions, and defined storage formulation support reproducible ELISA, western blot, immunohistochemistry, and imaging workflows.

• T0070907: A Practical PPARγ Antagonist Guide

  2026-09-22

  T0070907 is a high-affinity PPARγ antagonist for separating receptor-dependent transcription from downstream cellular effects. This guide covers assay setup, adipogenesis inhibition, PPARγ/RXRα heterodimer modulation, macrophage inflammation studies, and cell-cycle troubleshooting.

8058 records 1/538 page Next 12345 下5页 Last page